NCT06805409 VExUS in Ards Patients and Association with AKI
| NCT ID | NCT06805409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-12-02 |
| Primary Completion | 2027-12-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-12-02 with a primary completion date of 2027-12-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.
Eligibility Criteria
Inclusion Criteria: * Patients ≥18 years old * Moderate to severe ARDS according to the Berlin definition * Requiring catecholamine support * Undergoing invasive mechanical ventilation for less than 48 hours Exclusion Criteria: * Patients presenting with acute kidney injury KDIGO III requiring renal replacement therapy before the initial ultrasound evaluation * Requirement for veno-venous or veno-arterial ECMO circulatory support before inclusion * Patients with end-stage chronic kidney disease, on dialysis, and/or kidney transplant recipients * History of Child C cirrhosis and/or liver transplantation and/or portal hypertension * History of portal thrombosis * Known history of pulmonary hypertension * Pregnant women * Patients under legal protection * Patients who have expressed opposition to participating in the research
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06805409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06805409 currently recruiting?
Yes, NCT06805409 is actively recruiting participants. Contact the research team at romain.arrestier@aphp.fr for enrollment information.
Where is the NCT06805409 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT06805409 clinical trial?
NCT06805409 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 120 participants.